Alfieri Cardiology

Newark, Delaware 19713

0 studies enrolling now · 12 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Atrial Flutter, Bradycardia, Cardiovascular Disease, Coronary Artery Disease, Coronary Artery Disease (CAD), Healthy, Homozygous Familial Hypercholesterolemia, Myocardial Ischemia, Myocardial Perfusion Imaging, Venous Thrombosis

Studies at this site

• LOWER: Lomitapide Observational Worldwide Evaluation Registry — Completed
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. — Completed
• A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response — Completed
• Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease — Stopped early
• Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent — Stopped early
• Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease — Completed